bpc-157 safety evidence human trials clinical BPC-157: Experimental Peptide Creates Risk for Athletes Exciting news for peptides coming bpc-157 human clinical trial evidence

Epinephrine is added for its vasoconstricting properties, which helps reduce bleeding during the procedure

Independent reviewers consistently note that rodent-model time courses do not transfer one-for-one to humans

**Special Populations:** Dosage adjustments may be necessary for patients with renal impairment or other underlying health conditions

While effective, its pigment-inducing capacity limits its use in research

Testing & COA: Every product is third-party tested for purity and identity, with a per-batch certificate of analysis available in Kois public COA library on the website

This product is not a medicine, food or dietary supplement and is not suitable for human consumption